We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Biotech Biz Zymergen Lands $400M Series C Funding

Law360 (December 13, 2018, 4:42 PM EST) -- Molecular manufacturing technology company Zymergen said on Thursday that it has raised over $400 million in its latest round of funding that it will use to accelerate product development and commercialization....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.